News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
239 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (176)
2 (7)
3 (6)
4 (219)
5 (189)
6 (212)
7 (230)
8 (95)
9 (2)
10 (7)
11 (143)
12 (249)
13 (209)
14 (213)
15 (105)
16 (3)
17 (5)
18 (200)
19 (228)
20 (201)
21 (239)
22 (96)
23 (3)
24 (6)
25 (203)
26 (268)
27 (220)
28 (279)
29 (127)
30 (2)
31 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Alligator Bioscience AB: Interim report January-September 2021
“We continued to make great strides in the third quarter of 2021. The first patient was dosed in OPTIMIZE-1, our clinical Phase II study, that will assess the effect of mitazalimab in first line pancreatic cancer.
October 21, 2021
·
4 min read
Business
MDxHealth Provides Q3-2021 Business Update
MDxHealth SA, a commercial-stage precision diagnostics company, provided a business update for the third quarter ended September 30, 2021.
October 21, 2021
·
6 min read
Companion Animal Vaccines Market to Observe Strong Development by 2024
Companion animals such as dogs, cats, and horses are growing as a part of the urban population.
October 21, 2021
·
7 min read
GMP Cell Banking Services Market Survey | Know the Post-Pandemic Scenario of the Market
A cell bank refers to a facility that helps in the storage of cells of certain genome for future use in medicinal needs or in some product.
October 21, 2021
·
4 min read
Europe to Remain at the Epicenter of Kidney Stone Management Devices Market Growth
Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest Fact.MR analysis, the global kidney stone management devices market is forecast to register a healthy compound annual growth rate between 2021 and 2031.
October 21, 2021
·
8 min read
Dermatology CRO Market | Increasing Cases of Different Skin Disorders Drive the Industry Growth
The dermatology CRO market is projected to experience significant growth opportunities in the forthcoming years.
October 21, 2021
·
4 min read
Meibography Market set to record exponential growth by 2025 end
Meibomian glands play a vital role in the production of tear, and the dysfunction of these glands leads to evaporative dry eye disease.
October 21, 2021
·
5 min read
Business
The Joint Corp. to Host Conference Call on Thursday, November 4th to Discuss Third Quarter 2021 Results
The Joint Corp. announced it will report its third quarter 2021 financial results on Thursday, November 4, 2021, after the market close.
October 21, 2021
·
1 min read
Drug Development
Matinas BioPharma Initiates Dosing in Phase 1 Study of Potential First Oral Aminoglycoside Antibiotic Drug MAT2501
Matinas BioPharma Holdings, Inc. today announced that it has dosed the first patient in a Phase 1 single ascending dose (SAD) pharmacokinetic study in healthy volunteers with MAT2501.
October 21, 2021
·
7 min read
Business
NeuroMetrix Reports Q3 2021 Financial Results
NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2021.
October 21, 2021
·
6 min read
Previous
4 of 24
Next